Taysha Gene Therapies News

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(4.4%),VHCP Co-Investment Holdings III, LLC(4.4%), etc.

Nov 14 17:56 ET

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.

Nov 14 17:51 ET

Taysha Gene Therapies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avoro Capital Advisors LLC(9.99%),Behzad Aghazadeh(9.99%)

Nov 14 09:46 ET

Taysha Gene Therapies | 10-Q: Q3 2024 Earnings Report

Nov 13 16:44 ET

Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13 16:17 ET

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(9.113%),Abigail P. Johnson(9.113%)

Nov 12 10:42 ET

Taysha Gene Therapies | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.6%)

Nov 8 14:28 ET

Taysha Gene Therapies | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.6%)

Oct 22 18:11 ET

Taysha Gene Therapies | 10-Q: Q2 2024 Earnings Report

Aug 12 08:36 ET

Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12 08:10 ET

Taysha Gene Therapies | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 5 17:52 ET

Taysha Gene Therapies | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 5 17:52 ET

Taysha Gene Therapies | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 5 17:52 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-10% Owner Manning Paul B

Jul 1 08:03 ET

Taysha Gene Therapies | 8-K: Current report

Jun 26 17:19 ET

Taysha Gene Therapies | 424B5: Prospectus

Jun 26 17:14 ET

Taysha Gene Therapies | 8-K: Current report

Jun 26 06:18 ET

Taysha Gene Therapies | 424B5: Prospectus

Jun 26 06:08 ET

Taysha Gene Therapies | 8-K: Current report

Jun 18 07:48 ET

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Director Donenberg Phillip B.

May 31 16:28 ET